These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 20444603
1. Flexible ligand recognition of peroxisome proliferator-activated receptor-gamma (PPARgamma). Yamagishi K, Yamamoto K, Mochizuki Y, Nakano T, Yamada S, Tokiwa H. Bioorg Med Chem Lett; 2010 Jun 01; 20(11):3344-7. PubMed ID: 20444603 [Abstract] [Full Text] [Related]
2. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells. Awais M, Sato M, Umezawa Y. Biosens Bioelectron; 2007 May 15; 22(11):2564-9. PubMed ID: 17095203 [Abstract] [Full Text] [Related]
3. A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator. Seethala R, Golla R, Ma Z, Zhang H, O'Malley K, Lippy J, Cheng L, Mookhtiar K, Farrelly D, Zhang L, Hariharan N, Cheng PT. Anal Biochem; 2007 Apr 15; 363(2):263-74. PubMed ID: 17335769 [Abstract] [Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. Lin MS, Chen WC, Bai X, Wang YD. J Dig Dis; 2007 May 15; 8(2):82-8. PubMed ID: 17532820 [Abstract] [Full Text] [Related]
6. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. Ibabe A, Herrero A, Cajaraville MP. Toxicol In Vitro; 2005 Sep 15; 19(6):725-35. PubMed ID: 15964169 [Abstract] [Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Belvisi MG, Hele DJ, Birrell MA. Eur J Pharmacol; 2006 Mar 08; 533(1-3):101-9. PubMed ID: 16458290 [Abstract] [Full Text] [Related]
8. A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist. Chen Q, Chen J, Sun T, Shen J, Shen X, Jiang H. Anal Biochem; 2004 Dec 15; 335(2):253-9. PubMed ID: 15556564 [Abstract] [Full Text] [Related]
9. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide. Sommer M, Wolf G. Am J Nephrol; 2007 Dec 15; 27(4):425-34. PubMed ID: 17622750 [Abstract] [Full Text] [Related]
11. The differential interactions of peroxisome proliferator-activated receptor gamma ligands with Tyr473 is a physical basis for their unique biological activities. Einstein M, Akiyama TE, Castriota GA, Wang CF, McKeever B, Mosley RT, Becker JW, Moller DE, Meinke PT, Wood HB, Berger JP. Mol Pharmacol; 2008 Jan 14; 73(1):62-74. PubMed ID: 17940191 [Abstract] [Full Text] [Related]
12. NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma). Romeiro NC, Sant'Anna CM, Lima LM, Fraga CA, Barreiro EJ. Eur J Med Chem; 2008 Sep 14; 43(9):1918-25. PubMed ID: 18222570 [Abstract] [Full Text] [Related]
13. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids. Waku T, Shiraki T, Oyama T, Fujimoto Y, Maebara K, Kamiya N, Jingami H, Morikawa K. J Mol Biol; 2009 Jan 09; 385(1):188-99. PubMed ID: 18977231 [Abstract] [Full Text] [Related]
14. The dipeptide H-Trp-Glu-OH shows highly antagonistic activity against PPARgamma: bioassay with molecular modeling simulation. Ye F, Zhang ZS, Luo HB, Shen JH, Chen KX, Shen X, Jiang HL. Chembiochem; 2006 Jan 09; 7(1):74-82. PubMed ID: 16317783 [Abstract] [Full Text] [Related]
15. S 26948: a new specific peroxisome proliferator activated receptor gamma modulator with potent antidiabetes and antiatherogenic effects. Carmona MC, Louche K, Lefebvre B, Pilon A, Hennuyer N, Audinot-Bouchez V, Fievet C, Torpier G, Formstecher P, Renard P, Lefebvre P, Dacquet C, Staels B, Casteilla L, Pénicaud L, Consortium of the French Ministry of Research and Technology. Diabetes; 2007 Nov 09; 56(11):2797-808. PubMed ID: 17704298 [Abstract] [Full Text] [Related]
16. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties. Fujimura T, Kimura C, Oe T, Takata Y, Sakuma H, Aramori I, Mutoh S. J Pharmacol Exp Ther; 2006 Aug 09; 318(2):863-71. PubMed ID: 16682454 [Abstract] [Full Text] [Related]
17. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. Johnson BA, Wilson EM, Li Y, Moller DE, Smith RG, Zhou G. J Mol Biol; 2000 Apr 28; 298(2):187-94. PubMed ID: 10764590 [Abstract] [Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells. Ogawa D, Nomiyama T, Nakamachi T, Heywood EB, Stone JF, Berger JP, Law RE, Bruemmer D. Circ Res; 2006 Apr 14; 98(7):e50-9. PubMed ID: 16556873 [Abstract] [Full Text] [Related]
19. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo. Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC. Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980 [Abstract] [Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells. Yasugi E, Horiuchi A, Uemura I, Okuma E, Nakatsu M, Saeki K, Kamisaka Y, Kagechika H, Yasuda K, Yuo A. Dev Growth Differ; 2006 Apr 01; 48(3):177-88. PubMed ID: 16573735 [Abstract] [Full Text] [Related] Page: [Next] [New Search]